Consonance Capital

Consonance Capital Management as of March 31, 2014

Portfolio Holdings for Consonance Capital Management

Consonance Capital Management holds 27 positions in its portfolio as reported in the March 2014 quarterly 13F filing

Company (Ticker) Portfolio Weight Valued At Change in Shares Share Count Share Price
United Therapeutics Corporation (UTHR) 9.4 $63M 670k 94.03
Myriad Genetics (MYGN) 8.9 $60M 1.7M 34.19
Furiex Pharmaceuticals 8.0 $54M 617k 87.00
Enanta Pharmaceuticals (ENTA) 7.5 $50M 1.3M 39.99
BioScrip 5.2 $35M 5.0M 6.98
Aegerion Pharmaceuticals 5.2 $35M 759k 46.18
Insys Therapeutics 5.0 $33M 802k 41.43
Orthofix International Nv Com Stk 4.9 $33M 1.1M 30.15
Anacor Pharmaceuticals In 4.8 $32M 1.6M 20.01
Taro Pharmaceutical Industries (TARO) 4.5 $31M 275k 111.00
Masimo Corporation (MASI) 4.4 $30M 1.1M 27.31
Osiris Therapeutics 4.0 $27M 2.1M 13.13
Hyperion Therapeutics 3.9 $27M 1.0M 25.80
Vanda Pharmaceuticals (VNDA) 3.0 $20M 1.2M 16.25
Intuitive Surgical (ISRG) 2.4 $16M 37k 437.98
WuXi PharmaTech 2.4 $16M 431k 36.86
Infinity Pharmaceuticals (INFIQ) 2.2 $15M 1.3M 11.89
Flamel Technologies 2.1 $14M 1.0M 13.40
Clovis Oncology 2.1 $14M 201k 69.27
Galena Biopharma 2.0 $14M 5.4M 2.50
Derma Sciences 1.7 $11M 892k 12.68
Ophthotech 1.6 $11M 311k 35.67
Healthways 1.5 $10M 594k 17.14
Biosante Pharmaceuticals (ANIP) 1.2 $7.9M 251k 31.35
Akorn 1.0 $6.5M 295k 22.00
Pernix Therapeutics Holdings 1.0 $6.5M 1.2M 5.35
Liposcience 0.2 $1.4M 443k 3.19